ScholarIQanswers from OpenAlex
Mesenchymal stem cell therapy for severe COVID-19
PaperCitations, authors & open-access status
Mesenchymal stem cell therapy for severe COVID-19 is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Mesenchymal stem cell therapy for severe COVID-19 have?
ScholarIQcitation count
Mesenchymal stem cell therapy for severe COVID-19 has 135 citations in the OpenAlex counts ScholarIQ stores.
When was Mesenchymal stem cell therapy for severe COVID-19 published?
ScholarIQyear
Mesenchymal stem cell therapy for severe COVID-19 has 2021 year in the ScholarIQ index.
What is the open-access status of Mesenchymal stem cell therapy for severe COVID-19?
ScholarIQoa status
Mesenchymal stem cell therapy for severe COVID-19 has gold oa status in the ScholarIQ index.
What is the DOI of Mesenchymal stem cell therapy for severe COVID-19?
ScholarIQdoi
The DOI for Mesenchymal stem cell therapy for severe COVID-19 is on the source record.
What is the PMID of Mesenchymal stem cell therapy for severe COVID-19?
ScholarIQpmid
The PMID for Mesenchymal stem cell therapy for severe COVID-19 is on the source record.
What is the OpenAlex record for Mesenchymal stem cell therapy for severe COVID-19?
ScholarIQopenalex
The OpenAlex for Mesenchymal stem cell therapy for severe COVID-19 is on the source record.